Clinical Trial Update: R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing R-ICE versus R-DHAP in adults 18-65 with relapsed diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-DHAP
• R-ICE

Snippet

Sponsor: Lymphoma Study Association | Conditions: Lymphoma, Large-Cell, Diffuse | Phase 3 | Status: COMPLETED